Progression-free survival exceeding four years after transarterial embolization for liver metastases from triple-negative breast cancer: a case report
{{output}}
Liver metastasis in triple-negative breast cancer (TNBC) is associated with an unfavorable prognosis. Prior studies have reported a median overall survival of approximately 3-15 months after the diagnosis of liver metastasis, with a 5-year survival rate of les... ...
